Suzhou Zelgen Biopharmaceuticals , Ltd. PEG Ratio

Suzhou Zelgen Biopharmaceuticals , Ltd. (688266.SS) currently reports a PEG ratio of -43.09. That is below the Healthcare sector average of 11.77. Use the charts on this page to explore Suzhou Zelgen Biopharmaceuticals , Ltd.'s PEG ratio history and peer comparisons.

Suzhou Zelgen Biopharmaceuticals , Ltd.'s PEG ratio of -43.09 is lower than the Healthcare sector average of 11.77. That is roughly 466.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Suzhou Zelgen Biopharmaceuticals , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At -43.09, 688266.SS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -43.09, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.77. From there, open related valuation or income-statement pages for Suzhou Zelgen Biopharmaceuticals , Ltd., and consider following 688266.SS for alerts when major investors trade the stock.

Suzhou Zelgen Biopharmaceuticals , Ltd. is classified in the Healthcare sector. On PEG ratio, it currently shows -43.09 versus a sector average near 11.77. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 688266.SS with unrelated industries.